Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerResearch Summary
Analyzed using Evidence Intelligence™
QCC Model Enhances Diabetes Management
Last updated July 18, 2026
Key finding
The EG demonstrated significant improvements in fasting C-peptide levels compared to the RG.
The study evaluated the QCC nursing model's impact on blood glucose control in Type 2 diabetes patients, finding significant improvements in various metabolic markers.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Long-Term (1–5 y)
Risk of bias
Some Concerns
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
The study evaluated the QCC nursing model's impact on blood glucose control in Type 2 diabetes patients, finding significant improvements in various metabolic markers.
Clinical relevance
Effective management of blood glucose levels is crucial for Type 2 diabetes patients to prevent complications. The QCC nursing model not only improved metabolic outcomes but also enhanced patient satisfaction, indicating a holistic approach to diabetes care that could lead to better long-term health outcomes.
Keep in mind
The study's sample size may limit generalizability. Potential confounding factors were not fully controlled. The follow-up duration may not capture long-term effects.
Published in
Journal Reference
Publication details and source links for this paper.
Qing Z, Li Z, Yan G, Hua M, Yaping G, Guohong Z. The QCC Nursing Model Improves Blood Glucose Control in Type 2 Diabetes Patients. Journal of Medical Biochemistry. 2025;44(6):1288-1296. doi:10.5937/jomb0-55738
Main Effects
The EG demonstrated a significant decrease in fasting C-peptide levels by 1.5 ng/mL (p=0.01).
The EG showed a significant reduction in fasting plasma glucose levels by 2 mmol/L (p=0.02).
The EG had a significant improvement in glycated hemoglobin levels, decreasing by 0.5% (p=0.05).
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Insulin therapy, Usual care and C-peptide, Fasting Plasma Glucose (FPG), Fasting insulin levels, and 3 more.
This study contributes evidence to
Primary intervention
Insulin therapy
Primary outcomes
- C-peptide
- Fasting Plasma Glucose (FPG)
- Fasting insulin levels
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
12
Evidence pairs
12
Relationships
6
Evidence topics
contributes_evidence
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
Moderate contributionModerate confidenceNetwork score: 72
6
Related topics
12
Evidence pairs
1401
Related studies
High relevance in at least one topic
Why it is useful
- Contributes to 12 evidence relationships
- Includes primary outcome data
- Linked to 6 direct semantic evidence topics
Topic contributions
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Add related evidence to your Evidence Tracker
Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.
Primary evidence
Evidence relationship
Insulin Therapies and HbA1c
Related evidence
Evidence relationship
Insulin Therapies and Fasting Glucose
Save evidence
Evidence relationship
Insulin Therapies and Insulin Resistance
Save evidence
Core evidence
Study findings
The primary outcomes reported in this study.
Fasting insulin levels
Insulin therapy → Fasting insulin levels
Insulin therapy → Fasting insulin levels
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerFasting Plasma Glucose (FPG)
Insulin therapy → Fasting Plasma Glucose (FPG)
Insulin therapy → Fasting Plasma Glucose (FPG)
Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 2 studies
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- 83
- Strong
- ImpactScore™
- 83
- Positive
- ConsistencyScore™
- 67
- generally_consistent
Supporting studies: Based on 6 studies
Add to Evidence TrackerPostprandial blood glucose
Insulin therapy → Postprandial blood glucose
Insulin therapy → Postprandial blood glucose
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerTreatment satisfaction
Insulin therapy → Treatment satisfaction
Insulin therapy → Treatment satisfaction
Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 75
- Positive
- ConsistencyScore™
- 35
- mixed
Supporting studies: Based on 2 studies
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerFasting Plasma Glucose (FPG)
Usual care → Fasting Plasma Glucose (FPG)
Usual care → Fasting Plasma Glucose (FPG)
Evidence Intelligence™
- EvidenceScore™
- 85
- Strong
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 5 studies
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- 86
- Strong
- ImpactScore™
- 58
- Slightly Positive
- ConsistencyScore™
- 91
- consistent
Supporting studies: Based on 12 studies
Add to Evidence TrackerPostprandial blood glucose
Usual care → Postprandial blood glucose
Usual care → Postprandial blood glucose
Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 2 studies
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerEvidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Evidence Suggest
- Fasting plasma glucose decreased significantly by 2 mmol/L in the EG.
- Patient satisfaction in the EG was substantially higher than in the RG.
- Glycated hemoglobin improved by 0.5% in the EG group.
Who this applies to
- Adults diagnosed with Type 2 diabetes.
- Patients requiring insulin therapy.
- Individuals seeking improved diabetes management strategies.
Keep in Mind
- Results may not apply to all diabetes populations.
- The intervention's effectiveness may vary based on individual patient characteristics.
- Further studies are needed to confirm long-term benefits.
Between the Lines
- The study's sample size may limit generalizability.
- Potential confounding factors were not fully controlled.
- The follow-up duration may not capture long-term effects.
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Usual care and HbA1c, Usual care and Fasting Glucose.
Related evidence relationships
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
Behavioral & Lifestyle
Usual care → HbA1c
Behavioral & Lifestyle
Evidence Intelligence™
- EvidenceScore™
- 86
- Strong
- ImpactScore™
- 58
- Slightly Positive
- ConsistencyScore™
- 91
- consistent
Supporting studies: Based on 12 studies
View evidenceBehavioral & Lifestyle
Usual care → Fasting Glucose
Behavioral & Lifestyle
Evidence Intelligence™
- EvidenceScore™
- 85
- Strong
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 5 studies
View evidenceIncluded in these evidence collections
Curated evidence collections and hubs this study is part of.
HbA1c Evidence Hub
All studies measuring HbA1c
12 studies
outcome_hubMeasures HbA1c as a key outcome.
Usual care Evidence Hub
All studies on Usual care
12 studies
intervention_hubContributes to Usual care evidence base.
Fasting Glucose Evidence Hub
All studies measuring Fasting Glucose
5 studies
outcome_hubMeasures Fasting Glucose as a key outcome.
Recent Diabetes Research
Latest published studies
recency_collection
Published within the last 2 years.
Explore more in Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on Usual care and HbA1c
Intervention: Usual careOutcome: HbA1c
12 results
All studies on Usual care and Fasting Plasma Glucose (FPG)
Intervention: Usual careOutcome: Fasting Plasma Glucose (FPG)
5 results
All studies on Usual care
Intervention: Usual care
12 results
All studies measuring HbA1c
Outcome: HbA1c
12 results
All studies measuring Fasting Plasma Glucose (FPG)
Outcome: Fasting Plasma Glucose (FPG)
5 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Do Insulin Therapies lower HbA1c?
Strong Evidence
Insulin Therapies may lower HbA1c.
ConsistencyScore™: Results are generally consistent across studies.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 83.3 | moderate positive | ConsistencyScore™ Generally Consistent | 1 study
Why this answer: This answer is based on 15 supporting studies with generally consistent results and a positive effect signal.
Do Insulin Therapies improve fasting glucose?
Strong Evidence
Insulin Therapies may improve fasting glucose.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
Fasting Plasma Glucose (FPG)
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 1 study
Why this answer: This answer is based on 9 supporting studies with consistent results and a positive effect signal.
Do Insulin Therapies improve insulin resistance?
Strong Evidence
Insulin Therapies appear to improve insulin resistance.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
Fasting insulin levels
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on 6 supporting studies with consistent results and a positive effect signal.
Do Insulin Therapies improve postprandial and ogtt glucose?
Strong Evidence
Insulin Therapies may improve postprandial and ogtt glucose.
ConsistencyScore™: Results are generally consistent across studies.
Ranked evidence signals
- 1
Postprandial blood glucose
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on 5 supporting studies with generally consistent results and a positive effect signal.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Evidence topics
Follow the topics this study contributes to.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
Related research
Read related research summaries.
Semaglutide with Insulin Improves Diabetes Control and Kidney HealthEducational intervention improves glycemic control in type 2 diabetes patientsHRS-7535 improves glycemic control in adults with type 2 diabetesVildagliptin improves glycemic control in type 2 diabetes patients on insulinBariatric surgery improves glucose homeostasis in type 2 diabetes.
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.